India's Cipla launches etanercept biosimilar

MUMBAI, April 17 Wed Apr 17, 2013 7:17am EDT

Related Topics

MUMBAI, April 17 (Reuters) - Indian drugmaker Cipla Ltd said on Wednesday it has launched etanercept biosimilar in India under the brand name Etacept.

The drug, used to treat rheumatic disorders, is manufactured by China's Shanghai CP Guojian Pharmaceutical Co and would be sold by Cipla in India through a partnership, it said in a statement. (Reporting by Kaustubh Kulkarni; Editing by Bijoy Koyitty)

A couple walks along the rough surf during sunset at Oahu's North Shore, December 26, 2013. REUTERS/Kevin Lamarque

Find your dream retirement town

Florida? Hawaii? Reuters has teamed up with Zillow to give you the power to customize a list of your best places to retire.  Video | Full Article